The use of modern telemedicine technologies in an innovative optimal cardiac rehabilitation program for patients after myocardial revascularization: Concept and design of RESTORE, a randomized clinical trial.
Adolescent
Adult
Aged
Cardiac Rehabilitation
/ adverse effects
Diet, Healthy
Exercise
Female
Humans
Male
Middle Aged
Multicenter Studies as Topic
Myocardial Ischemia
/ diagnostic imaging
Myocardial Revascularization
/ adverse effects
Patient Education as Topic
Poland
Prospective Studies
Randomized Controlled Trials as Topic
Risk Factors
Risk Reduction Behavior
Telemedicine
Time Factors
Treatment Outcome
Young Adult
myocardial revascularization
optimal cardiac rehabilitation
reduced rehospitalization rate
tele-rehabilitation
Journal
Cardiology journal
ISSN: 1898-018X
Titre abrégé: Cardiol J
Pays: Poland
ID NLM: 101392712
Informations de publication
Date de publication:
2019
2019
Historique:
received:
25
09
2018
accepted:
08
11
2018
pubmed:
20
12
2018
medline:
29
7
2020
entrez:
20
12
2018
Statut:
ppublish
Résumé
Despite proven efficacy of cardiac rehabilitation (CR) in reducing the all-cause mortality in patients after myocardial revascularization, the penetration of CR, due to patient-related factors and referral rates remains limited. To improve the outcomes, home-based tele-rehabilitation (TR) has been proposed recently. In theory TR enhances the effects of standard CR procedures due to implementation of an intelligent monitoring system designed to ensure optimal training through on-demand transmission of vital signs, aimed at motivating the patients through daily schedule reminders, setting daily goals and creating a platform for mutual feedback. Several meta-analyses assessing various studies comparing these two methods (CR and TR) have proven that they are at least equally effective, with some of the research showing superiority of TR. Although there was a small sample size, lack of long-term follow-up, reporting effects of TR itself, no integration with tools designed for coaching, motivating and promoting a healthy lifestyle constitutes an important limitation. The latter carries a hopeful prognosis for improvement when utilizing a broad-spectrum approach, especially with use of dedicated technological solutions exploiting the fact of a large and yet rapidly increasing penetration of smartphones, mobile PCs and tablets in the population. The above-mentioned findings worked as the basis and rationale for commencing the RESTORE project aimed at developing and delivering state-of-the-art, comprehensive TR for patients after myocardial revascularization and evaluating its molecular aspect in view of how it influences the atherosclerosis progression attenuation. This paper presents the current state and rationale behind the project based on up-to-date TR efficacy data.
Identifiants
pubmed: 30566211
pii: VM/OJS/J/60138
doi: 10.5603/CJ.a2018.0157
pmc: PMC8084403
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
594-603Références
J Cardiopulm Rehabil Prev. 2015 Nov-Dec;35(6):380-9
pubmed: 26034937
Lancet. 2009 Mar 14;373(9667):929-40
pubmed: 19286092
Int J Cardiol. 2016 Oct 15;221:963-9
pubmed: 27441476
Eur Heart J. 2015 Apr 21;36(16):950-1
pubmed: 25899410
Eur Heart J Qual Care Clin Outcomes. 2018 Jul 1;4(3):168-172
pubmed: 29325067
Eur Heart J. 2003 Jul;24(13):1273-8
pubmed: 12831822
Heart. 2016 Aug 1;102(15):1183-92
pubmed: 26936337
Int J Cardiol. 2015 Jan 20;179:153-9
pubmed: 25464436
Cochrane Database Syst Rev. 2000;(4):CD001800
pubmed: 11034729
Cochrane Database Syst Rev. 2017 Jun 30;6:CD007130
pubmed: 28665511
Kardiol Pol. 2015;73(3):142-58
pubmed: 25371307
Eur J Prev Cardiol. 2016 Dec;23(18):1914-1939
pubmed: 27777324
Eur Heart J Acute Cardiovasc Care. 2015 Dec;4(6):509-17
pubmed: 25301783
Circulation. 2007 Oct 9;116(15):1653-62
pubmed: 17893274
J Telemed Telecare. 2015 Jan;21(1):45-53
pubmed: 25475219
Eur J Prev Cardiol. 2015 Aug;22(8):959-71
pubmed: 25488550
Int J Rehabil Res. 2005 Sep;28(3):251-7
pubmed: 16046919
J Am Coll Cardiol. 2015 Jun 23;65(24):2652-2659
pubmed: 26088305
Open Heart. 2016 Sep 14;3(2):e000463
pubmed: 27738516
Prog Cardiovasc Dis. 2014 Mar-Apr;56(5):522-9
pubmed: 24607017
J Am Coll Cardiol. 2008 Apr 29;51(17):1619-31
pubmed: 18436113
J Am Coll Cardiol. 2009 Jun 30;54(1):25-33
pubmed: 19555836
Circulation. 1989 Aug;80(2):234-44
pubmed: 2665973
Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):939
pubmed: 27692125
Phys Ther. 2015 Feb;95(2):167-79
pubmed: 25278337